Treatment of postmenopausal osteoporosis

Authors

  • E. Loza

Keywords:

Osteoporosis postmenopáusica. Tratamiento. Bifosfonatos. Raloxifeno. Calcitonina.

Abstract

Prevention and treatment of osteoporosis consists of non-drug and drug therapy. This review of the topic will provide an overview of the approach to therapy of osteoporosis in postmenopausal women. In the past, estrogen replacement was considered a primary therapy for the prevention of postmenopausal osteoporosis. However, data from the Women´s Health Initiative (WHI) revealed that estrogen-progestine therapy does not reduce the risk of coronary heart disease, and increases the risk of breast cancer, stroke, and venous thromboembolic events. As a result of these findings, other antiresorptive agents are now the drugs of choice for the prevention and treatment of osteoporosis in postmenopausal women.

Downloads

Download data is not yet available.

Published

2008-12-15

How to Cite

Loza, E. (2008). Treatment of postmenopausal osteoporosis. Anales Del Sistema Sanitario De Navarra, 26, 91–98. Retrieved from https://recyt.fecyt.es/index.php/ASSN/article/view/4976

Issue

Section

Research articles